KCT0000059
Recruiting
未知
Multicenter, open-labeled, single-arm group trial for the interval of surveillance colonoscopy after polypectomy
ConditionsNeoplasms
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Neoplasms
- Sponsor
- Hanyang University Guri Hospital
- Enrollment
- 2000
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients who underwent polypectomy for adenomas during screening colonoscopy
Exclusion Criteria
- •Patients with advanced colon cancer, previous colon surgery, chronic inflammatory bowel disease, familial adenomatous polyposis, and those with refusal of consent to the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Open-label single-arm, multicenter clinical trial to evaluate patient acceptability of a new CREON formulation of Pancreas Powder gastro-resistant pellets in patients with cystic fibrosis suffering from pancreatic exocrine insufficiency.patients with cystic fibrosis suffering from pancreatic exocrine insufficiencyMedDRA version: 21.0Level: PTClassification code: 10079428Term: Cystic fibrosis gastrointestinal disease Class: 100000004850Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]CTIS2023-503256-27-00MEDA Pharma GmbH & Co. KG80
Active, not recruiting
Phase 1
A Study to Evaluate Long Term Safety, Tolerability, and Effectiveness of Olesoxime in Patients with Spinal Muscular AtrophySpinal Muscular AtrophyMedDRA version: 20.1 Level: LLT Classification code 10051203 Term: Spinal muscular atrophy congenital System Organ Class: 100000004850Therapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2015-001589-25-PLF. Hoffmann-La Roche Ltd131
Active, not recruiting
Phase 1
A Study to Evaluate Long Term Safety, Tolerability, and Effectiveness of Olesoxime in Patients with Spinal Muscular AtrophySpinal Muscular AtrophyMedDRA version: 20.1Level: LLTClassification code 10051203Term: Spinal muscular atrophy congenitalSystem Organ Class: 100000004850Therapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2015-001589-25-GBF. Hoffmann-La Roche Ltd131
Active, not recruiting
Phase 1
A Study to Evaluate Long Term Safety, Tolerability, and Effectiveness of Olesoxime in Patients with Spinal Muscular AtrophySpinal Muscular AtrophyMedDRA version: 20.1Level: LLTClassification code 10051203Term: Spinal muscular atrophy congenitalSystem Organ Class: 100000004850Therapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2015-001589-25-BEF. Hoffmann-La Roche Ltd173
Active, not recruiting
Phase 1
A Study to Evaluate Long Term Safety, Tolerability, and Effectiveness of Olesoxime in Patients with Spinal Muscular AtrophySpinal Muscular AtrophyMedDRA version: 20.1 Level: LLT Classification code 10051203 Term: Spinal muscular atrophy congenital System Organ Class: 100000004850Therapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2015-001589-25-DEF. Hoffmann-La Roche Ltd131